Tarsus Pharmaceuticals (TARS) EV to CFO (2021 - 2026)
Tarsus Pharmaceuticals' (TARS) EV to CFO stood at 33.42 in Q2 2026.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) EV to CFO (2021 - 2026) Analysis & Trends
On a TTM basis, Tarsus Pharmaceuticals' EV to CFO came in at 22.51 as of Jun 30, 2026; for FY2021, it came in at 78.42.
- The Q2 2026 figure is the highest quarterly EV to CFO since Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Tarsus Pharmaceuticals | 3.06 Bn | 2.01 Bn | 161.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.42 |
| Mar 31, 2022 | 676.50 |
| Dec 31, 2021 | 78.42 |
| Sep 30, 2021 | 44.79 |
API Access
Tarsus Pharmaceuticals EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();